NCT04229784 (RF-GREP) is a NA clinical trial of Radiofrewuency surgery in Hemorrhoids, sponsored by Ramsay Générale de Santé.

Who is sponsoring NCT04229784?

NCT04229784 is sponsored by Ramsay Générale de Santé.

What drugs are being tested in NCT04229784?

Interventions in NCT04229784: Radiofrewuency surgery.

What condition does NCT04229784 study?

NCT04229784 studies Hemorrhoids, Surgical Procedure, Unspecified.

Is NCT04229784 still recruiting?

NCT04229784 is currently status unknown. Last updated 18 January 2020.

Last reviewed 2020-01-18 · How we verify

NCT04229784: RF-GREP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multicentrique Prospective Evaluation of Radiofrequency Surgical Treatment of Homorrhoidal Disease

Status unknown NA Last updated 18 January 2020

What this trial tests

NA trial testing Radiofrewuency surgery in Hemorrhoids in 150 participants. Status unknown.

Timeline

1 July 2019

Primary endpoint
31 July 2021

31 July 2021

Quick facts

Lead sponsor	Ramsay Générale de Santé
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	150
Start date	1 July 2019
Primary completion	31 July 2021
Estimated completion	31 July 2021
Sites	1 location across France

Drugs / interventions tested

Radiofrewuency surgery

Conditions studied

Hemorrhoids — all drugs for Hemorrhoids →
Surgical Procedure, Unspecified — all drugs for Surgical Procedure, Unspecified →

Sponsor

Ramsay Générale de Santé — full company profile →

Who can join

Adults 18 to 75, any sex, with Hemorrhoids or Surgical Procedure, Unspecified. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hemorrhoids consist of a tissue rich in blood vessels and are present in all individuals inside the anus. Hemorrhoidal disease (HD) is when hemorrhoids become troublesome and cause symptoms such as pain, bleeding, prolapse or seepage. The first steps in the treatment of HD involve either drugs or instrumental gestures (sclerosis, ligation). In the event of failure or of a disease that is significant from the outset, it is possible to envisage a surgical treatment. The use of a radiofrequency is a new technique, already used frequently by vascular surgeons in the treatment of varicose veins of the lower limbs. This technique has been developed for radiofrequency destruction of hemorrhoidal vascular tissue. In France, no studies have been carried out to evaluate this new technique.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

French multicentre prospective evaluation of radiofrequency ablation in the management of haemorrhoidal disease.
Laurain A, Bouchard D, Rouillon JM, Petit P, et al · · 2023 · cited 3× · PMID 37005961 · DOI 10.1007/s10151-023-02787-1

Verify or expand the search:

Other recruiting trials for Hemorrhoids

Currently open trials in the same condition.

NCT07350460 — PUSHES (Pudendal Block Versus Sacral ESP Hemorrhoidectomy Study) · NA · recruiting
NCT07317492 — HEMOVAR Study on Hemorrhoids and Varicose Veins · recruiting
NCT05782010 — SCI-Pex Study - Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids · NA · recruiting
NCT05697562 — Evaluation of Superior Rectal Arterial Embolization in Hemorrhoidal Disease · NA · recruiting
NCT03972956 — Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease · recruiting

Other Ramsay Générale de Santé trials

Trials by the same sponsor.

NCT07353060 — Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT) · NA · not yet recruiting
NCT07245823 — Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineo · NA · recruiting
NCT07142330 — Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries · not yet recruiting
NCT07203131 — Evaluation of the Impact of an Alteration of NAD+ Metabolism on the Renal Prognosis of Patients Admitted to Intensive Ca · NA · recruiting
NCT07469007 — Impact of Surgery for Deep Posterior Endometriosis on Ovarian Reserve (ENDORO) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04229784 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ramsay Générale de Santé
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04229784.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing